drug
Next-generation CAR-T
Preclinicalupdated 6mo agoby ToolGen Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- Rebranded Galapagos finally finds buyer for unwanted cell therapy pipelineLakefront Biotherapeutics—the new name for Belgium’s Galapagos Therapeutics—has found a buyer for its unwanted cell therapy pipeline.fiercebiotech · 1mo ago
- Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effectsA new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…fiercebiotech · 3mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that